World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
15423
World Ranking
3004
National Ranking
114

Peter Heeringa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter Heeringa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 324 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter Heeringa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Heeringa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter Heeringa is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. They have published extensively within several subfields, including immunology, pulmonary and respiratory medicine, immunology and allergy, rheumatology, and molecular biology.

The scientist's work covers a range of topics, with a primary focus on vasculitis and related conditions. Other main topics of research include cell adhesion molecules, otitis media and relapsing polychondritis, atherosclerosis and cardiovascular diseases, coagulation and related mechanisms, neutrophil and oxidative mechanisms, and cellular mechanics and interactions.

Peter Heeringa has collaborated frequently with several coauthors. Notable collaborators include William F. Jiemy, Elisabeth Brouwer, Kornelis S. M. van der Geest, Wayel H. Abdulahad, and Maria Sandovici.

Their recent papers include the following:

  • Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis, 2020, Clinical & Translational Immunology
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells, 2021, Cells
  • A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis, 2021, Arthritis & Rheumatology
  • Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort, 2023, RMD Open
  • Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing, 2022, The Journal of Experimental Medicine

Peter Heeringa frequently publishes in several academic venues. These include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • UNC Libraries
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Autoimmunity

Best Publications

  • Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

    Hong Xiao;Peter Heeringa;Peiqi Hu;Zhi Liu

  • Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

    Hong Xiao;Adrian Schreiber;Peter Heeringa;Ronald J. Falk

  • Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease

    Betty S. van der Veen;Menno P. J. de Winther;Peter Heeringa

  • Protective role of endothelial nitric oxide synthase

    Ester W J A Albrecht;Coen A Stegeman;Peter Heeringa;Robert Henning

  • Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.

    Esther Lutgens;Marion Gijbels;Marjan Smook;Peter Heeringa

  • The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies

    Hong Xiao;Peter Heeringa;Zhi Liu;Dennis Huugen

  • Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils

    Bart de Vries;Jörg Köhl;Wouter K. G. Leclercq;Tim G. A. M. Wolfs

  • High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice

    Roel A. van der Heijden;Fareeba Sheedfar;Martine C. Morrison;Pascal P. H. Hommelberg

  • Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis

    Aleeza J. Roth;Joshua D. Ooi;Jacob J. Hess;Mirjan M. Van Timmeren

  • Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice

    D. Huugen;A. van Esch;H. Xiao;C.-J. Peutz-Kootstra

  • Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

    Abraham Rutgers;Marjan Slot;Pieter van Paassen;Peter van Breda Vriesman

  • Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides

    Cees G M Kallenberg;Peter Heeringa;Coen A Stegeman

  • Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.

    A. H. L. Mulder;P. Heeringa;E. Brouwer;P. C. Limburg

  • Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.

    Dennis Huugen;Hong Xiao;Anita van Esch;Ronald J. Falk

  • Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis

    Guang-qun Xing;Min Chen;Gang Liu;Peter Heeringa

  • Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice

    Marcella van Leeuwen;Marion J. J. Gijbels;Adriaan Duijvestijn;Marjan Smook

  • Neutrophil activation in vitro and in vivo in Wegener's granulomatosis

    Elisabeth Brouwer;Minke G. Huitema;A.H. Leontine Mulder;Peter Heeringa

  • Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.

    Bart de Vries;Robert A. Matthijsen;Tim G. A. M. Wolfs;Annemarie A. J. H. M. van Bijnen

  • Myeloperoxidase attracts neutrophils by physical forces

    Anna Klinke;Claudia Nussbaum;Lukas Kubala;Kai Friedrichs

  • High Prevalence of Autoantibodies to hLAMP-2 in Anti–Neutrophil Cytoplasmic Antibody–Associated Vasculitis

    Renate Kain;Henko Tadema;Eoin F. McKinney;Alexandra Benharkou

Frequent Co-Authors

Coen A. Stegeman
Coen A. Stegeman University Medical Center Groningen
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Grietje Molema
Grietje Molema University Medical Center Groningen
Jan Willem Cohen Tervaert
Jan Willem Cohen Tervaert University of Alberta
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Robert Kleemann
Robert Kleemann Netherlands Organisation for Applied Scientific Research
Harry van Goor
Harry van Goor Radboud University
J. Charles Jennette
J. Charles Jennette University of North Carolina at Chapel Hill
Pieter C. Limburg
Pieter C. Limburg University of Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many professionals in immunology pursue nursing pathways, which offer practical experience with patient care and clinical research. For those looking to fast-track their nursing education, accelerated FNP programs provide an efficient route to becoming a Family Nurse Practitioner with an emphasis on patient health and disease prevention.

If you’re starting with little or no nursing background, online RN programs for non nurses offer accessible options to earn a Registered Nurse license through flexible, online coursework. For those seeking quicker entry into nursing, accelerated nursing programs allow students to complete their Bachelor of Science in Nursing in a shorter timeframe, preparing them for advanced roles within immunology-related clinical care.

Additionally, easy admission LPN programs can serve as a stepping stone for individuals aiming to enter the healthcare field quickly. Licensed Practical Nurses support patient care teams, gaining experience that could complement future studies in immunology or other specialized healthcare sectors.

Best Scientists Citing Peter Heeringa

Trending Scientists

Recently Published Articles